In medicine, autoimmune polyendocrine syndromes are a heterogeneous group of rare diseases characterised by autoimmune activity against more than one endocrine organs, although non-endocrine organs can be affected.
There are three "autoimmune polyendocrine syndromes", and a number of other diseases which have endocrine autoimmunity as one of their features.
The syndromes
Type 1
Autoimmune polyendocrine syndrome, type 1 is also known as the
candidiasis-
hypoparathyroidism-
Addison's disease-syndrome after its main features:
As opposed to type 2, this syndrome inherits in an autosomal recessive fashion and is due to a defect in AIRE ("autoimmune regulator"), a gene located on the 21st chromosome. Normal function of AIRE, a transcription factor, appears to be to confer immune tolerance for antigens from endocrine organs.
Type 2
Autoimmune polyendocrine syndrome, type 2 (also known as "Schmidt's syndrome") is more heterogeneous, occurs more often and has not been linked to one
gene. Rather, patients are at a higher risk when they carry a particular
HLA genotype (DQ2, DQ8 and DRB1*0404).
Features of this syndrome are:
- Addison's disease
- hypothyroidism
- diabetes mellitus (type 1)
- less common associations:
Some researchers favour splitting this syndrome into three distinct syndromes (numbering 2, 3 and 4), but research evidence for these distinct combinations is not convincing.
XPID
The most serious but rarest form is the
X-linked polyendocrinopathy, immunodeficiency and diarrhea-syndrome. This is due to mutation of the
FOXP3 gene on the X chromosome. Most patients develop diabetes and diarrhea as neonates and many die due to autoimmune activity against many organs. Boys are affected, while girls are carriers and might suffer mild disease.
Other diseases
Other diseases featuring polyendocrine autoimmunity:
Management
In principle, the component diseases are managed as usual. The challenge is to detect the possibility of any of the above syndromes, and to anticipate other manifestations. For example, in a patient with known Type 2 autoimmune polyendocrine syndrome but no features of
Addison's disease, regular screening for
antibodies against 21-hydroxylase (a feature of Addison's) may prompt early intervention and
hydrocortisone replacement to prevent characteristic crises.
Sources
- Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004;350:2068-79. PMID 15141045.
Endocrinology | Autoimmune diseases